Literature DB >> 758466

Effect of sulfisoxazole on pharmacokinetics of free and plasma protein-bound bilirubin in experimental unconjugated hyperbilirubinemia.

S Oie, G Levy.   

Abstract

The effect of sulfisoxazole on the time course of free (unbound) bilirubin concentrations in plasma was studied. Normal adult rats were made hyperbilirubinemic by continuous intravenous infusion of bilirubin. Sulfisoxazole was administered by either rapid intravenous injection or slow intravenous infusion, and the plasma concentrations of free and total (free plus bound) unconjugated bilirubin were determined as a function of time. Rapid injection of sulfisoxazole caused a rapid and pronounced decrease of total bilirubin concentrations in plasma but had only a transient effect on the concentration of free bilirubin. Slow infusion of sulfisoxazole caused a gradual and eventually pronounced decrease of total bilirubin concentrations in plasma but had no apparent effect on the concentration of free bilirubin at any time. These results are consistent with recently developed pharmacokinetic theory according to which the plasma clearance of total bilirubin should increase upon administration of a displacing agent while the plasma clearance of free bilirubin should remain unchanged. Bilirubin-induced encephalopathy caused by sulfisoxazole or other displacing agents may be due to very transient elevations of free bilirubin concentrations in plasma of infants with elevated plasma concentrations of total bilirubin and the consequent redistribution of the pigment to extravascular sites, including the brain.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758466     DOI: 10.1002/jps.2600680106

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

Review 1.  The blood-brain barrier and bilirubin encephalopathy.

Authors:  R P Wennberg
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

Review 2.  Protein binding drug displacement interactions fact or fiction?

Authors:  J J MacKichan
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

Review 3.  The immunosuppressive effects of bilirubin.

Authors:  V Vĕtvicka; P Síma; I Miler; M Bilej
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

4.  Effect of a protein binding change on unbound and total plasma concentrations for drugs of intermediate hepatic extraction.

Authors:  R H Smallwood; G W Mihaly; R A Smallwood; D J Morgan
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

5.  Kinetics of drug displacement interactions.

Authors:  L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1981-04

Review 6.  Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement.

Authors:  P C Walker
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

7.  Ceftriaxone--bilirubin-albumin interactions in the neonate: an in vivo study.

Authors:  E Martin; S Fanconi; P Kälin; C Zwingelstein; C Crevoisier; W Ruch; R Brodersen
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

8.  Pharmacokinetics of the hepatic transport of organic anions: influence of extra- and intracellular binding on hepatic storage of dibromosulfophthalein and interactions with indocyanine green.

Authors:  D K Meijer; A Blom; J G Weitering; R Hornsveld
Journal:  J Pharmacokinet Biopharm       Date:  1984-02

Review 9.  Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2014-09-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.